Expression of matrix metalloproteinase-9 and significance of a macrophage assay in eosinophilic granuloma

Annals of Diagnostic Pathology

Volumn 13, Issue 6, 2009, Pages 367-372

  Zyada, Manal Mohamed ^a  

^a Mansoura University   (Egypt)

Author keywords

Eosinophilic granuloma; Immunohistochemistry; Macrophage; Matrix metalloproteinase 9

Indexed keywords

ANTIBODY; AVIDIN; BIOTIN; CD68 ANTIGEN; GELATINASE B;

ARTICLE; CELL ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHILIC GRANULOMA; HISTIOCYTOSIS X; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BONE AND BONES; CELL COUNT; EOSINOPHILIC GRANULOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MATRIX METALLOPROTEINASE 9;

EID: 71549135828     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2009.06.009     Document Type: Article

References (41)

1. Arceci R.J., Longley B.J., and Emanuel P.D. Atypical cellular disorders. Hematology Am Soc Hematol Educ Program (2002) 297-314
2. Laman J.D., Leenen P.J., Annels N.E., Hogendoorn P.C., and Egeler R.M. Langerhans-cell histiocytosis "insight into DC biology". Trends Immunol 24 (2003) 190-196
3. Milan M.A., Bagan J.V., Jimenez Y., Perez A., Scully C., and Antoniadis D. Langerhans cell histiocytosis restricted to the oral mucosa. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91 (2001) 76-79
4. Favara B.E., and Jaffe R. The histopathology of Langerhans cell histiocytosis. Br J Cancer 70 Suppl. (1994) 17-23
5. Cochrane L.A., Prince M., and Clarke K. Langerhans' cell histiocytosis in pediatric population: presentation and treatment of head and neck manifestation. J Otolaryngeal 32 1 (2003) 33-37
6. Chen B.F., and Liang D.C. A clinicopathologic study of Langerhans' cell histiocytosis. Chung HUA I Heush T sa Chih (Taipei) 54 (1994) 116-121
7. De Graaf J.H., and Egeler R.M. New insights into the pathogenesis of Langerhans' cell histiocytosis. Curr Opin Pediatr 9 1 (1997) 46-50
8. Schouten B., Egeler R.M., Leenen P.J., Taminian A.H., Van Den Broekl J., and Hogendoom P.C. Expression of cell cycle-related gene production in Langerhans' cell histiocytosis. J Pediatr Hematol Oncol 24 9 (2002) 727-732
9. Eckardt A., and Schultze A. Maxillofacial manifestations of Langerhans' cell histiocytosis: a clinical and therapeutic analysis of ten patients. Oral Oncol 39 7 (2003) 687-694
10. Tortorici S., Burruano F., Maresi E., Caradonna L., Leone P.D.A., Buscemi M., et al. Mandibulary eosinophilic granuloma: case series. J Med Sci 2 2 (2008) 65-68
11. Finneg D.S., Reest D., Wright J.M., and Blanton P.L. Solitary eosinophilic granuloma (histiocytosis X) of the gingival. A report of 2 cases. J Periodontol 59 (1988) 457-460
12. Engsig M.T., Chen Q.J., Vu T.H., et al. Matrix metalloproteinases-9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 151 4 (2000) 879-890
13. Blavier L., and Delaisse J.M. Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. J Cell Sci 108 12 (1995) 3649-3659
14. Coussens L.M., Fingleton B., and Matrisian L.M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295 (2002) 2387-2392
15. Suomela S., Kariniemi A.L., Snellman E., and Saarialho-Kere U. Metalloelastase (MMP-12) and 92-kDa gelatinase (MMP-9) as well as their inhibitors, TIMP-1 and -3, are expressed in psoriatic lesions. Exp Dermatol 10 3 (2001) 175-183
16. Sanceau J., Boyd D.D., Seiki M., and Bauvois B. Interferons inhibit tumor necrosis factor-∞ mediated matrix metalloproteinases-9 activation via interferon regulatory factor-1 binding competition with NF-KB. J Biol Chem 277 (2002) 35766-35775
17. Brinckerhoff C.E., and Matrisian L.M. Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 3 (2002) 207
18. Kumta S.M., Huang L., Cheng Y.Y., Chow L.T., Lee K.M., and Zheng M.H. Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions. Life Sci 73 (2003) 1427-1436
19. Hermann E., Darcissac E., Idziorer T., Capron A., and Bahr G.M. Recombinant interleukin-16 selectively modulates surfaces receptor expression and cytokines release in macrophages and dendritic cells. Immunology (1999) 241-248
20. Chetty R., and Cvijan D. Giant (bizarre) cell variant of renal cell carcinoma. Histopathology 30 (1997) 585-587
21. Pulford K.A.F., Rigney E.M., Micklem K.J., Jones M., Stross W.P., Gatter K.C., et al. KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol 42 (1989) 414-421
22. Torrealba J.R., Fernandez L.A., Kanmaz T., Oberley T.D., Schultz J.M., Brunner K.G., et al. Immunotoxin-treated rhesus monkeys: a model for renal allograft chronic rejection. Transplantation 76 3 (2003) 524-530
23. Liu Z.H., Chen S.F., Zhou H., Chen H.P., and Li L.S. Glomerular expression of C-C chemokines in different types of human crescentic glomerulonephritis. Nephrol Dial Transplant 18 8 (2003) 1526-1534
24. Pizov G., and Friedlaender M.M. Immunohistochemical staining for proliferation antigen as a predictor of chronic graft dysfunction and renal graft loss. Nephron 92 3 (2002) 738-742
25. Fayyazi A., Schweyer S., Eichmeyer B., Herms J., Hemmerlein B., Radzun H.J., et al. Expression of IFN-gamma, co-expression of TNF-alpha and matrix metalloproteinases and apoptosis of T lymphocytes and macrophages in granuloma annulare. Arch Dermatol Res 292 (2000) 384-390
26. Vaalamo M., Kariniemi A.L., Shapiro S.D., and Saarialho-Kere U. Enhanced expression of human metalloelastase (MMP-12) in cutaneous granulomas and macrophage migration. J Invest Dermatol 112 (1999) 499-505
27. Valleala H, Hanemaaijer R, Mandelin J, Salminen A, Teronen O, Monkkonen J, et al. Regulation of MMP-9 (gelatinase B) in activated human monocyte/macrophages by two different types of biophosphonates. Life Sci 73;2413-2420.
28. Favara B.E., Feller A.C., Pauli M., Jaffe E.S., Weiss L.M., Arico M., et al. Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol 29 (1997) 157-166
29. In: Naish S.J. (Ed). Handbook-immunohistochemical staining methods (1989), Carpinteria, DAKO Corporation
30. Berti E., Passoni E., Marzano A.V., and Caputo R. Unusual variants of non-Langerhans cell histiocytoses. J Am Acad Dermatol 57 6 (2007) 1031-1045 [Abstract quot]
31. Smets A., Mortele K., de Praeter G., Francois O., Benoit Y., and Kunnen M. Pulmonary and mediastinal lesions in children with Langerhans cell histiocytosis. Pediatr Radiol 27 11 (1997) 873-876 [Abstract quot]
32. Shimakage M., Sasagawa T., Kimura M., Shimakage T., Seto S., et al. Expression of Epstein-Barr virus in Langerhans' cell histiocytosis. Hum Pathol 35 (2004) 862-8687
33. Favara B.E., and Steele A. Langerhans cell histiocytosis of lymph nodes: a morphological assessment of 43 biopsies. Pediatr Pathol Lab Med 17 (1997) 769-787
34. Geissmann F., Lepelletier Y., Fraitag S., Valladeau J., Bodemer C., et al. Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood 97 (2001) 1241-1248
35. Yoo J., Jung J.H., Kang S.J., and Kang C.S. Expression of matrix metalloproteinase-9 correlates with poor prognosis in human malignant fibrous histocytoma. Cancer Res Treat 36 6 (2004) 348-388
36. Felx M., Guyot M.C., Isler M., Turcotte R.E., Doyon J., Khatib A.M., et al. Endothelin-1 (ET-1) promotes MMP-2 and MMP-9 induction involving the transcription factor NF-κB in human osteosarcoma. Clin Sci 110 (2006) 645-654
37. Kohalmi F., Strausz J., Egervary M., and Szekeres G. Expression of macrophage markers in childhood and adult Langerhans cell histiocytosis (LCH). Ovr Hetil 138 22 (1997) 1399-1402
38. Geissman F., Lepelletier Y., Fraitage S., Valladeau J., Bodemer C., Debre M., et al. Differentiation of Langerhan cells in Langerhans cell histiocytosis. Blood 97 5 (2001) 1241-1248
39. Gutierrez M., Forster F.I., McConnell S.A., Cassidy J.P., Polloek J.M., and Bryson D.B. The detection of CD2+, CD4+, CD8+ and WCL+ T lymphocytes, B cells and macrophages in fixed and paraffin embedded bovine tissue using a range of antigen recovery and signal amplification techniques. Vet Immunol Immunopathol 71 3-4 (1999) 321-334
40. Mazal P.R., Karen A.F.P., David Y.M., Alberto C., Stefania U., Stefano P., et al. Expression of macrophage-associated antigens in tissues involved by Langerhans' cell histiocytosis (histiocytosis X). Am J Clin Pathol 92 (1989) 273-279
41. Luigi P.R., Karen A.F.P., David Y.M., Alberto C., Stefania U., Stefano P., et al. Expression of macrophage-associated antigens in tissues involved by Langerhans' cell histiocytosis(histiocytosis X). Am J Clin Pathol 92 (1989) 273-279